Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
3,364,694
-
Share change
-
+124,940
-
Total reported value
-
$3,432,000
-
Price per share
-
$1.02
-
Number of holders
-
10
-
Value change
-
-$82,580
-
Number of buys
-
5
-
Number of sells
-
7
Institutional Holders of ASLAN PHARMACEUTICALS LTD - ADS (ASLN) as of Q1 2020
As of 31 Mar 2020,
ASLAN PHARMACEUTICALS LTD - ADS (ASLN) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,364,694 shares.
The largest 10 holders included
Temasek Holdings (Private) Ltd, Sio Capital Management, LLC, PLATINUM INVESTMENT MANAGEMENT LTD, DAFNA Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, BANK OF MONTREAL /CAN/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, UBS Group AG, and DEUTSCHE BANK AG\.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.